608
Participants
Start Date
January 31, 2007
Primary Completion Date
February 28, 2014
Study Completion Date
February 28, 2014
Losartan Potassium
Losartan .3 - 1.4 mg/kg
Atenolol
Atenolol .5 - 4 mg/kg
Weill Medical College of Cornell University, New York
Mount Sinai Medical Center, New York
Columbia College of Physicians and Surgeons, New York
Children's Hospital of Pittsburgh, Pittsburgh
Children's Hospital of Philadelphia, Philadelphia
Hospital of the University of Pennsylvania, Philadelphia
Johns Hopkins University School of Medicine, Baltimore
Wake Forest University Baptist Medical Center, Winston-Salem
Duke University Medical Center, Durham
Brody School of Medicine at East Carolina University, Greenville
Medical University of South Carolina, Charleston
Vanderbilt University Medical Center, Nashville
Cincinnati Children's Hospital Medical Center, Cincinnati
Children's Hospital of Minnesota - St. Paul, Saint Paul
Children's Memorial Hospital, Chicago
Washington University School of Medicine, St Louis
Texas Children's Hospital, Houston
Primary Children's Medical Center, Salt Lake City
Cedars-Sinai Medical Center, Los Angeles
Rady Children's Hospital / UCSD, San Diego
Lucile Packard Children's Hospital, Palo Alto
Stanford University School of Medicine, Stanford
Seattle Children's Hospital, Seattle
Children's Hospital Boston, Boston
Ghent University Hospital, Ghent
Hospital for Sick Children, Toronto
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
NIH
FDA Office of Orphan Products Development
FED
National Marfan Foundation
UNKNOWN
Carelon Research
OTHER